Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)

SHA:688578 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	588.61	586.99	1,862	470.49	615.36	365.84
Short-Term Investments	-	280	230	-	20	-
Trading Asset Securities	3,060	2,759	419.6	1,567	1,625	2,225
Cash & Short-Term Investments	3,649	3,626	2,512	2,037	2,260	2,591
Cash Growth	36.38%	44.37%	23.29%	-9.86%	-12.78%	173.64%
Accounts Receivable	364.15	389	260.17	150.85	14.83	0.29
Other Receivables	2.11	29.26	29.07	6.82	3.58	2.28
Receivables	366.26	418.26	289.24	157.68	18.42	2.57
Inventory	29.44	30.56	62.95	32.07	20.8	10.78
Prepaid Expenses	-	2.15	3.18	2.5	-	-
Other Current Assets	437.65	103.21	40.79	56.69	75.42	74.69
Total Current Assets	4,482	4,180	2,908	2,286	2,375	2,679
Property, Plant & Equipment	516.79	516.37	526.64	539.94	404.03	206.88
Long-Term Investments	169.39	244.4	145.26	52.73	38.37	20
Other Intangible Assets	64.87	65.38	66.49	68.45	67.29	69.18
Long-Term Deferred Tax Assets	0	0	-	11.5	-	-
Long-Term Deferred Charges	189.82	168.12	0.71	0.57	2.11	2.71
Other Long-Term Assets	811.75	741.45	729.5	482.76	243.79	8.93
Total Assets	6,235	5,916	4,376	3,442	3,130	2,987
Accounts Payable	54.31	27.39	13.25	5.15	1.75	3.44
Accrued Expenses	172.46	482.4	314.33	152.68	96.96	93.58
Current Portion of Leases	1.91	0.99	1.43	1.66	4.72	-
Current Income Taxes Payable	99.72	67.45	5.4	6.98	-	0.36
Current Unearned Revenue	-	-	-	0.1	0.18	-
Other Current Liabilities	245.91	22.37	55.62	88.04	52.51	11.63
Total Current Liabilities	574.3	600.6	390.03	254.62	156.12	109.01
Long-Term Leases	2.01	0.3	0.39	0.3	0.68	-
Long-Term Deferred Tax Liabilities	17.52	28.77	0.14	-	-	-
Other Long-Term Liabilities	3.65	3.65	3.65	0.2	0.2	-
Total Liabilities	597.48	633.32	394.22	255.12	156.99	109.01
Common Stock	450	450	450	450	450	450
Additional Paid-In Capital	3,261	3,254	3,175	3,100	3,031	2,957
Retained Earnings	1,812	1,401	264.02	-380.16	-510.68	-528.95
Comprehensive Income & Other	114.14	177.89	93.63	17.61	3.25	-
Shareholders' Equity	5,637	5,283	3,982	3,187	2,973	2,878
Total Liabilities & Equity	6,235	5,916	4,376	3,442	3,130	2,987
Total Debt	3.92	1.3	1.82	1.96	5.39	-
Net Cash (Debt)	3,645	3,625	2,510	2,035	2,255	2,591
Net Cash Growth	36.31%	44.42%	23.32%	-9.73%	-12.99%	209.60%
Net Cash Per Share	8.10	8.06	5.57	4.52	4.94	7.01
Filing Date Shares Outstanding	450	450	450	450	450	450
Total Common Shares Outstanding	450	450	450	450	450	450
Working Capital	3,908	3,580	2,518	2,032	2,219	2,570
Book Value Per Share	12.53	11.74	8.85	7.08	6.61	6.40
Tangible Book Value	5,572	5,217	3,916	3,119	2,906	2,809
Tangible Book Value Per Share	12.38	11.59	8.70	6.93	6.46	6.24
Buildings	-	508.81	494.91	470.35	116.73	116.73
Machinery	-	156.45	132.04	140.27	88.34	75.36
Construction In Progress	-	5.19	18.58	13.8	266.57	78.44

Source: S&P Global Market Intelligence. Standard template. Financial Sources.